News and Trends 14 Feb 2023
BiPER Therapeutics raises €1.25M to develop small molecules to treat gastrointestinal cancers
BiPER Therapeutics, a French preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat gastrointestinal cancers, has raised €1.25 million ($1.35 million) in seed funding. BiPER Therapeutics received…